In vitro transcription of immunoglobulin genes in a B-cell extract: effects of enhancer and promoter sequences by Sen, Ranjan & Baltimore, David
MOLECULAR AND CELLULAR BIOLOGY, May 1987, p. 1989-1994 Vol. 7, No. 5
0270-7306/87/051989-06$02.00/0
Copyright © 1987, American Society for Microbiology
In Vitro Transcription of Immunoglobulin Genes in a B-Cell Extract:
Effects of Enhancer and Promoter Sequences
RANJAN SEN AND DAVID BALTIMORE*
Whitehead Institute for Biomedical Research, Cambridge, Massachusetts 02142,* and Department of Biology,
Massachusetts Institute of Technology, Cambridge, Massachusetts 02139
Received 27 May 1986/Accepted 7 January 1987
Transfection experiments have led to the identification of three DNA sequences that are responsible for the
tissue-specific expression of immunoglobulin genes. As a first step toward characterizing these regulatory
phenomena at the biochemical level, we report the development of an in vitro transcription system from ceUs
of the B lymphoid lineage. In these extracts, transcription of the MOPC41 K promoter is correctly initiated and
dependent on the presence of an upstream sequence element located between -44 and -79 base pairs from the
cap site. Second, although standard in vitro transcriptions are not affected by the presence or absence of
enhancer sequences, we observed that the addition of polyethylene glycol led to a B-cell extract-specific
suppression of transcription from a template that carries an immunoglobulin enhancer.
As part of the effort to understand tissue-specific activa-
tion and repression of genes, studies on the transcription of
DNA transfected into tissue culture cells have begun to
define sequences critical for regulating gene expression. For
immunoglobulin genes, regulatory sequences have been lo-
calized at both the heavy- and the K light-chain loci. It has
been established that the promoters of both the heavy- and
light-chain immunoglobulin genes exhibit some tissue spec-
ificity (of about 10- to 30-fold) (9, 12, 15, 16, 23). A second
element is the tissue-specific enhancer (3, 4, 14, 16, 27, 29,
31-34) located in the intron between the variable and con-
stant regions. Although originally identified as sequences
that dramatically increased the levels of transcription of
transfected genes, enhancers have now been shown to
exhibit other properties as well. For example, several recent
reports (19, 43, 44) claim that an enhancer on an endogenous
heavy-chain gene may be lost without affecting the transcrip-
tion level, implying a role for activation but not maintenance
of a transcriptionally active state. Further, under certain
cellular conditions, the simian virus 40 enhancer (5, 42) as
well as the immunoglobulin enhancers (18) have been shown
to have repressorlike properties. Finally, a third element has
been implicated in the regulation of the heavy-chain gene,
but not yet localized (16). Each element appears to be
necessary but not sufficient for directing high-level, accurate
transcription of a transfected gene. To further understand
the roles of these individual elements, a functional in vitro
assay would be of great value. Our first goal was, therefore,
to derive transcription extracts from a B-lymphoid cell type.
Second, having accomplished that, we were able to exam-
ine the role of the immunoglobulin upstream sequence
element in the in vitro transcription assay, finding that
transcription of a rearranged K immunoglobulin gene tem-
plate deleted of its upstream regulatory sequence is de-
creased about 10-fold relative to the wild-type template.
Third, under certain transcription conditions, templates car-
rying either the heavy-chain or the light-chain enhancer
placed upstream from the cap site transcribed less efficiently
than those templates deleted of enhancer sequences. This
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effect was cis acting and present only in B-cell extracts
derived from EW cells, but not in the heterologous HeLa cell
extracts.
Our initial attempts to derive transcription extracts from B
cells involved the mouse myeloma MPC 11. We found that
neither whole-cell extracts (22) nor nuclear extracts (7) made
from this cell line were capable of correctly initiating tran-
scription from a template containing an immunoglobulin
promoter. We were able to fractionate away an inhibitor and
reconstitute a transcription system, but because the fraction-
ation involved removing potentially important factors from
the extract, we did not pursue mouse cells further. The fact
that most standard transcription extracts are derived from
HeLa cells, a human cell line, prompted us to examine
extracts from human B-cell lines for their transcriptional
activity. Whole-cell extracts were made from two human
Burkitt lymphoma lines, EW and RAMOS, by the procedure
of Manley et al. (22). As demonstrated below, these extracts
were active.
The templates used for in vitro transcription reactions are
diagrammed in Fig. 1A. The template representing the
wild-type gene (pK) was derived from the MOPC41 K gene
and contained sequences from approximately 100 base pairs
(bp) upstream from the transcription initiation site (endpoint
5'A5, Fig. 1A) to the BglII site in the major JK-CK intron (25).
This fragment retains the complete variable region which is
rearranged to JK1, but not the K enhancer which is further
downstream of the BglII site (4, 33, 34). This short 5' flank
has been shown to be sufficient for accurate initiation and
high-level transcription of the gene in a transient transfection
assay (4). Deletion analysis of the K promoter showed
previously that important regulatory sequences are present
between nucleotides -79 and -44 because deletion 5'A7
completely abolished transcriptional competence of the gene
while deletion 5'A5 had no effect (4). The template repre-
senting an inactive promoter mutant (pAK) was constructed
by engineering a HindIII site into the 5' end of 5'A7 and
cloning the segment of the gene up to the BglII site into
pUC13 cut with HindIll and BamHI.
To examine transcriptional activity in B-cell extracts, we
did runoff transcription reactions at 30°C for 60 min. A
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FIG. 1. In vitro transcription in human B-cell extracts. (A) DNA
sequence of the promoter region of the MOPC41 K gene. The
deletions 5'A5 and 5'A7 have been described before (4). The highly
conserved octanucleotide sequence which is found upstream of all
sequenced heavy- and light-chain variable-region genes is boxed
(labeled OCTA). It is located approximately 30 bp upstream from
the TATA box. The plasmids PK and PAK were constructed by
converting the 5' ends of 5'A5 and 5'A7 into a HindIll site with
synthetic linkers followed by cloning the fragment up to the BgII
site in the JK-CK major intron into HindIII-BamHI-digested pUC13.
pKEK and pKE, represent plasmids containing either the K enhancer
or the heavy-chain enhancer cloned into the unique HindIII site of
pK. The segments used as the enhancers are an 800-bp HindIll-
MboII fragment from the JK-CK intron (25) and a 700-bp XbaI-EcoRI
fragment from the JH-C,, intron (3, 14). (B) Transcription in whole-
cell extracts made from the human B lymphoma cell lines RAMOS
(lanes 1 and 2) and EW (lanes 3 and 4) and from HeLa cells
(provided by A. Fire; lanes 5 and 6). The templates were linearized
at the Sacl site in the polylinker, and the expected 2.3-kb runoff
transcript is indicated.
typical reaction mix contained 9 ,ul (160 ,ug) of whole-cell
extract, 50 ,uM each ATP, CTP, and GTP, 0.5 ,uM UTP, 10
,uCi of [o_-32P]UTP (7,600 Ci/mol), 5 mM creatine phosphate,
0.3 mg of creatine phosphokinase (Sigma Chemical Co., St.
Louis, Mo.) per ml, 12 mM HEPES (N-hydroxyethylpiper-
azine-N'-2-ethanesulfonic acid) (pH 7.9), 12% glycerol, 60
mM KCl, 5 mM Mg2+, 1 mM EDTA, 0.6 mM dithiothreitol,
linearized template (-50 ng), and poly(dI-dC) (-400 ng).
After work up, the RNAs were glyoxalated and analyzed by
electrophoresis through a 1.4% agarose gel in 10 mM sodium
phosphate (pH 6.8)-i mM EDTA (22). A runoff transcript of
2.3 kilobases (kb) was evident when RAMOS, EW, or HeLa
cell extracts were used (Fig. 1B, lanes 2, 4, and 6). When a
K-chain enhancer sequence was added to the construct, no
effect was evident, implying that transcription in these
extracts is enhancer independent (Fig. 1B, lanes 1, 3, and 5).
(In EW and HeLa cells, the enhancer appears to cause a
slight increase in the background radioactivity but not in the
2.3-kb band.) The band at 2.3 kb could be abolished by not
adding the template or by transcribing in the presence of 0.5
Lg of a-amanitin per ml. Thus it represents a template-
-i3 specific RNA polymerase II transcript. The band just below
2.3 kb is not decreased by a-amanitin and presumably
reflects end labeling of endogenous 18S rRNA.
To assess whether initiation of transcription occurred at
the natural cap site, we used a second assay (17). For this
assay, the uniformly labeled RNA was hybridized to a
single-strand DNA probe spanning the transcription initia-
tion site (generated by cloning the PvuII-Sau3A [33] frag-
ment of the K gene into bacteriophage M13). The resulting
complex was digested with RNase Tl, and the RNase-
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FIG. 2. Effect of the upstream deletion 5'A7 on in vitro transcrip-
tion in B-cell extracts utilizing a preincubation pulse-chase protocol.
Runoff transcripts were obtained with templates containing either
the wild-type promoter (lane 1) or the truncated K promoter (lanes 2
and 3). Lanes 4 to 6, In vitro transcription with closed circular
templates containing the wild-type promoter (lane 4) or the trun-
cated K promoter (lanes 5 and 6). In these reactions 50 ng of a closed
circular template containing the adenovirus major late promoter
(MLP) was included as an internal control. The transcripts specific
to the K template or the adenovirus template are indicated as K and
MLP, respectively. For a template containing the major late pro-
moter we used the plasmid pFLBH which contains sequences from
14.7 to 17.0 map units of adenovirus inserted between the BamHI
and HindIll sites of pBR322 (kind gift of A. Fire and M. Samuels).
The upper of the two bands (K) derived from the immunoglobulin
promoter represents the correct start for K transcription. The lower
band is seen at variable intensities and probably does not represent
a different cap site, as explained in the text.
1990 NOTES
NOTES 1991
resistant RNA fragments were analyzed by electrophoresis
through a 6% polyacrylamide gel with 8.3 M urea. Analysis
of in vitro-synthesized RNA by this method is shown in Fig.
2 (lane 4). The upper band (labeled K) represents the correct
cap site. The band just below it was seen at variable
intensities (e.g., see Fig. 3D) and probably does not repre-
sent a different cap site but rather arises from cleavage with
RNase T1 at the next G residue from the 3' end of the
protected region. (Examination of the sequence near the
Sau3A1 site [33] shows that the second set of G residues on
the RNA lies 19 bp upstream from the end of the region of
homology with the single-stranded DNA probe.) Thus, the
extracts generated from B cells were capable of correctly
initiating and transcribing the immunoglobulin promoter in
vitro with approximately the same efficiency as a HeLa cell
extract.
To analyze the effect of 5'-flanking sequences in vitro, we
examined the transcription of the deleted gene, pAK. Be-
cause many regulatory effects act on the rate of initiation of
transcription, we chose to use a preincubation, pulse-chase
protocol which measures initiation rates (11). Either the
linearized or the supercoiled template (50 ng) was incubated
in a volume of 20 ,ul with 9 ,ul (-160 ,g) of EW extract, 6%
(wt/vol) polyethylene glycol (PEG) 20,000, and all other
components described above except the nucleotides for 60
min at 30°C. Transcription was then initiated by the addition
of nucleotides and radiolabeled UTP (final concentration, 60
,uM each ATP, CTP, and GTP, 1 ,uM UTP, and 10 ,uCi of
[a-32PIUTP). The initiating pulse was maintained for 10 min
at 30°C followed by a 10-min chase with a vast excess of
nonradioactive nucleotides (final concentrations, 330 ,uM
ATP, CTP, and GTP, 1 mM UTP). The reactions were
quenched, and the transcripts were analyzed by electropho-
retic separation. Incorporated radioactivity in this assay is
proportional to the number of correct initiations occurring
during the pulse. In Fig. 2, comparison of lanes 2 and 3 with
lane 1 shows that the template pK, which contains about 100
bp upstream of the initiation site, initiated approximately
10-fold more efficiently than did the deletion mutant PAK.
Again, the presence of the heavy-chain enhancer placed at
-44 bp to the truncated promoter did not alter the level of
transcription. (The upper band present in all lanes presum-
ably arises from end-to-end transcription of the linearized
plasmid which is often observed in such reactions and is
independent of the presence of regulatory sequences). When
closed circular templates were used, a similar effect of the
promoter truncation was observed (Fig. 2, lanes 4 to 6). In
these reactions a template containing the major late pro-
moter of adenovirus was included as an internal control (28).
Major late promoter-specific transcripts were detected with
the M13 clone XH11 (provided to us by A. Fire and M.
Samuels), and the expected protected RNA fragment of 180
bp is labeled MLP. Comparison of lanes 5 and 6 with lane 4
shows that there was a 10-fold decrease in the efficiency of
transcription from the mutant promoter, whereas the tran-
script of the major late promoter remained constant. The
reason for the apparent decrease in the amount of transcrip-
tion from the supercoiled template containing the heavy-
chain enhancer was not further addressed. It is evident,
however, that the dependence of transcription on an up-
stream sequence between -44 and -79 is observed whether
the template is linear or circular. To assess whether the
effect described above was specific to B-cell extracts, we
transcribed the same templates in the heterologous HeLa
whole-cell extract. A four- to fivefold decrease in transcrip-
tion was seen with the deleted template when compared with
the wild-type template (data not shown). Thus, the effect of
the deletion is, at best, only modestly tissue specific.
In EW cell extracts, the same level of RNA was generated
from two templates, one carrying and one deleted of the
immunoglobulin K enhancer (Fig. 1B). This was true in HeLa
extracts as well and was independent of whether the tem-
plate was linear or closed circular (data not shown). In
attempts to show enhancer effects in vitro, we varied a
number of obvious conditions individually, e.g., Mg2+,
Ca2+, NH4+, spermidine, time, but none of these conveyed
any template selectivity. However, as described below, the
addition of PEG to the transcription reaction did lead to a
suppression of transcription from a template carrying either
the heavy- or light-chain enhancer.
The plasmid pBRK was constructed by cloning the 2-kb
PvuII-BglII fragment of the rearranged MOPC41 K gene
containing the promoter, variable region, and extra JK seg-
ments in pBR322. The K enhancer, present on an 800-bp
HindIII-MboII fragment of the JK-CK intron (25), was in-
serted into the unique HindIII site in pBRK to generate the
plasmid pBRKEK (Fig. 3A). The orientation of the insert was
determined by cleaving with AvaIl which cuts once within
the enhancer and placed the essential 250 bp (marked by the
cross-hatched box) approximate 600 bp away from the cap
site. The plasmid pKE,, (Fig. 3B) was constructed from
plasmid pK by adding the 700-bp XbaI-EcoRI heavy-chain
complete enhancer fragment from the J,,-C,, intron (16)
upstream of the start site of transcription at the unique
HindIII site. The orientation of this insert placed the essen-
tial 300 bp (marked by the cross-hatched box) that retains 30
to 50% of the enhancer activity approximately 130 bp away
from the cap site.
To probe the effects of the enhancer sequences on the
initiation step of the transcription reaction, we again fol-
lowed the preincubation pulse-chase protocol. When the two
sets of plasmids described above were used as templates for
in vitro transcription reactions in the presence of 6% PEG
20,000, a striking difference in the extent of RNA produced
from each template was observed (Fig. 3C). The presence of
either the K enhancer (lanes 1 and 2) or the heavy-chain
enhancer (lanes 3 and 4) on a template led to a suppression
of transcription from that template. Most interestingly, this
effect was limited to transcription in a B-cell extract because
when the same templates were transcribed in a HeLa cell
extract, no difference in the levels of RNA was observed
(lanes 5 and 6). Use of closed circular plasmids as DNA
templates yielded the same results. In a B-cell extract, the
plasmid containing the heavy-chain enhancer transcribed 5-
to 10-fold less efficiently (Fig. 3D, lane 1) than a plasmid
lacking an enhancer (lane 2). Use of a plasmid (pFLBH)
containing the adenovirus major late promoter as an internal
control showed that the extent of transcription of this
promoter (lanes 1 and 2, labeled MLP) remained constant.
The repressive effect of the immunoglobulin enhancer was
observed only in the B-cell extract and not in HeLa extracts
(Fig. 3D, lanes 3 and 4). This effect was reproducibly
observed if the transcription conditions were kept constant
with a given cell extract. To observe maximal suppression
with an independently derived extract from the same cell
line, we often had to adjust the ratios of DNA template and
protein in the extract. This negative enhancer effect in B-cell
extracts was observed in the range of 50 to 150 mM KCl, but
was lost if the protein concentration in the reaction was
decreased by a factor of 4 from its optimal concentration.
Although transcription reactions in HeLa cell extracts were
done under a wide variety of different conditions, we never
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FIG. 3. Plasmids utilized for in vitro transcription reactions and
effect of immunoglobulin enhancer sequences in vitro. (A) pBRKEK
is a plasmid carrying the K enhancer which was derived from pBRK
as described in the text. The cross-hatched box represents the
essential 250 bp of the K enhancer. pBRK and pBRKEK were
linearized for runoff transcription assays by cutting with Sanl in the
pBR322 backbone. (B) pKE1. is a ,u enhancer-bearing plasmid and
was derived from pK (Fig. 1A). The cross-hatched box represents
the essential 300 bp of the ,u enhancer. Plasmids pK and pKE,1 were
linearized for runoff transcription assays by cutting with Sacl in the
polylinker. (C) Effect of immunoglobulin enhancer sequences on in
vitro transcription with linear templates. Runoff transcripts were
obtained with pBRKEK and pBRK as templates in B-cell extracts
(lanes 1 and 2) or in a HeLa cell extract (lanes 5 and 6) or with pKE,
and pK as templates in a B-cell extract (lanes 3 and 4). (D) Effect of
immunoglobulin enhancer sequences on in vitro transcription with
closed circular templates and the preincubation pulse-chase proto-
col. K-gene-specific radioactive RNA was selected by hybridization
to a single-stranded DNA probe spanning the initiation site of
transcription. A plasmid containing the adenovirus major late pro-
moter was included as an internal control in all transcription
reactions, and the resultant RNA is labeled MLP. RNA (labeled K)
was synthesized from templates with and without the immunoglob-
ulin heavy-chain enhancer in a B-cell extract (lanes 1 and 2) and in
a HeLa extract (lanes 3 and 4). Lane 5, End-labeled, HpaII-digested
pBR322 DNA.
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FIG. 4. Runoff transcription analysis of the effect of mixing
templates with and without the K enhancer sequence. Approxi-
mately 50 ng each of linearized templates pBRKEK and pBRK were
transcribed individually (lanes 1 and 2, respectively) or as an
equimolar mixture (lane 3) in a B-cell extract or in a HeLa cell
extract (lanes 4, 5, and 6). Transcriptions were done with 45%
(vol/vol) whole-cell extract and 25 ,ug of poly(dI-dC) poly(dI-dC)
per ml in the presence of 6% (wt/vol) PEG 20,000 following the
preincubation, pulse-chase protocol. The in vitro-synthesized RNA
was glyoxalated and analyzed by electrophoresis through a 1.4%
agarose gel.
detected differential transcription of templates as a conse-
quence of the presence of an immunoglobulin enhancer.
To examine whether the suppression of transcription was
mediated in cis upon the template carrying the enhancer, we
did experiments mixing templates pBRK and pBRKEK in the
same reaction. If the suppression described earlier was due
to depletion of some limiting transcription factor by binding
to the enhancer sequences, then a second template in the
reaction should also be adversely affected (i.e., in trans).
However, this was not so (Fig. 4). A negative effect of the
presence of the enhancer on the transcription of linearized
templates pBRK and pBRKEK in individual reactions was
observed (Fig. 4, lanes 1 and 2). However, when both
templates were present simultaneously in the same tran-
scription reaction, the amount ofRNA observed was similar
to that observed with pBRK alone (compare lanes 3 and 2),
thus showing that transcription of this template was not
repressed owing to its presence in the same reaction as
pBRKEK. When the same experiment was done in a HeLa
extract, once again the results were additive (Fig. 4, lanes 4,
5, and 6). In this case there was no pBRKEK template-
specific repression, thus yielding runoff transcripts of equiv-
alent amounts with either pBRK or pBRKEK (lanes 4 and 5)
and approximately double the amount in the mixed tran-
scription reaction (pBRK and PBRKEK) (lane 6). Further-
more, the fact that the levels of transcripts initiating from the
major late promoter (Fig. 3D) were unchanged in the pres-
ence of both plasmids pBRK and pBRKEK also argues
against the negative effect being mediated in trans by the
depletion of some limiting transcription factor. We therefore
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suggest that the observed repressive effect is cis acting upon
the plasmid that carries an immunoglobulin enhancer se-
quence and is specific to an extract derived from a B
lymphoid cell.
We reported here the development of transcriptionally
competent whole-cell and nuclear extracts from two inde-
pendent human B-cell lymphomas which should be useful for
the biochemical analysis of tissue-specific regulatory phe-
nomena. In such extracts, transcription from the promoter of
the MOPC41 K gene was correctly initiated, and a promoter
deletion significantly reduced the level of initiated RNA.
Furthermore, in the presence of 6% PEG, templates carrying
either the ,u or K enhancer transcribed less efficiently than
those deleted of enhancer sequences. This suppressive effect
was restricted to B-cell extracts only and not observed in
heterologous HeLa cell extracts. These effects may now be
used as functional assays during purification of the putative
factors that mediate them and thus set the stage for a more
refined biochemical and mechanistic analysis of immuno-
globulin gene transcription.
The sequences responsible for the tissue selectivity of the
immunoglobulin promoters have been narrowed down to a
150-bp fragment for the VH promoter (16) and a 220-bp
fragment for the VK promoters (12, 15). A strikingly con-
served octanucleotide sequence (ATT1GCAT) motif ap-
pears in these fragments and has been postulated to be a
recognition sequence for a tissue-specific regulatory protein
(10, 30). It is curious, therefore, that deletion of this se-
quence causes similar effects on the amounts of transcripts
generated in vitro in either B-cell extracts or the heterolo-
gous HeLa extract. This observation, however, is consistent
with the observation that both EW cells and HeLa cell
nuclear extracts contain a factor that binds specifically over
this sequence (41). Further, the same octamer sequence
motif has been shown to be of importance for the regulation
of non-B-cell-specific genes as well, e.g., the Ul and U2
small nuclear RNA genes (1, 24). Therefore, it is not
surprising that it binds a non-tissue-specific factor.
Hydrophilic polymers such as PEG and polyvinyl alcohol
have been essential components of in vitro replication reac-
tions in crude extracts (13) and more recently have been
used to increase the efficiency of in vitro splicing reactions
(20). These polymers are believed to have two effects on
these reactions. First, they promote the concatenation of
DNA into large aggregates (21) induced presumably by initial
condensation, and second, they increase the local concen-
tration of all macromolecules by an excluded volume effect
that has been called macromolecular crowding (45). What
the role of PEG is in bringing about an enhancer-dependent
suppression of in vitro transcription is not clear. It is
conceivable that compaction may make it easier for distant
sections of the DNA to interact with each other, and
macromolecular crowding may help bring about the binding
of relatively rare proteins with these sequences. Recently,
the simian virus 40 enhancer (35-37, 40) and the immuno-
globulin ,. enhancer (2, 37) have been shown to have a
positive effect on in vitro transcriptions. Examinations of the
conditions required to observe an enhancement in vitro
shows (i) the need to concentrate the nuclear extract and (ii)
a strong dependence on the presence of spermidine. Since
the latter is believed to promote condensation of DNA, the
combination should lead to conditions rather similar to those
generated in our reactions by the addition of PEG.
The paradoxical nature of extract-specific suppression of
in vitro transcription from a template carrying an immuno-
globulin enhancer requires some speculative explanation.
Even in experiments with the simian virus 40 enhancer only
a subset of the functional characteristics of that enhancer
have been mimicked in vitro. This has led to the argument
that perhaps an enhancer can operate at various levels (39),
and at the present state of refinement of in vitro systems only
a few of these can be mimicked simultaneously. More
specifically, there is evidence to suggest that functional
activation of an enhancer is a multicomponent phenomenon
in which there is a need for tissue-specific as well as
nonspecific trans-acting factors (26, 38). One possibility is
that we are reconstituting only partial function under our
assay conditions by only a subset of these factors interacting
with the enhancer, thus giving rise to the unexpected ob-
served inhibition. Further, it has recently been shown that
both the simian virus 40 and immunoglobulin enhancers are
the sites of negative regulation of transcription under certain
cellular conditions (5, 18, 42). Perhaps our in vitro conditions
mimic more closely these inhibitory conditions rather than
those that give enhancement. Another possibility is that
binding of the correct set of factors is inducing an inappro-
priate function because our assay is biased by our precon-
ceived notion of what the function of an enhancer is. For
example, if the role of the protein bound to the ,u enhancer
(6, 8) is not to serve as an entry site for RNA polymerase but
rather to define nuclear localization or to change chromatin
structure, then its effect in vitro would not necessarily be
seen as an increase in the number of polymerase molecules
accurately initiating transcription during the pulse in our
experiments.
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